高敏肌钙蛋白路径与急诊停留时间
这项回顾性质量改进研究在单一医疗系统4个城市急诊比较实施前常规肌钙蛋白检测(2021年6月1日至2022年3月31日)与实施后整合高敏肌钙蛋白路径(2022年6月1日至2023年3月31日)的差异。共分析16094例因胸痛就诊且有至少1次肌钙蛋白结果的成人患者,其中高敏肌钙蛋白队列8486例、常规肌钙蛋白队列7608例。实施高敏肌钙蛋白路径与平均急诊停留时间从6.18小时缩短至5.64小时相关;在收住院和离院患者中均观察到停留时间缩短,在需要连续肌钙蛋白检测的患者中评估至处置时间及首次肌钙蛋白医嘱至第二次结果时间均缩短。作者认为该结构化电子健康记录方法可能减轻高敏肌钙蛋白应用的运营挑战,并可作为改善胸痛患者急诊效率的可扩展模型。
要点
- 在4个城市急诊实施电子健康记录整合的高敏肌钙蛋白路径后,平均急诊停留时间从6.18小时(95%CI 6.10-6.26)降至5.64小时(95%CI 5.57-5.71)。
- 收住院患者平均急诊停留时间从10.50小时(95%CI 10.22-10.78)降至9.60小时(95%CI 9.35-9.87),P=0.003。
- 离院患者平均急诊停留时间从5.33小时(95%CI 5.26-5.40)降至5.02小时(95%CI 4.96-5.08),P=0.006。
- 接受2次及以上肌钙蛋白检测的患者,评估至处置时间从6.68小时(95%CI 6.52-6.85)缩短至5.06小时(95%CI 4.97-5.15),P<0.001。
- 收住院患者首次肌钙蛋白医嘱至第二次结果时间从5.16小时(95%CI 5.01-5.31)缩短至3.18小时(95%CI 3.11-3.25),离院患者从4.54小时(95%CI 4.46-4.62)缩短至2.78小时(95%CI 2.75-2.82),P均<0.001。
适用人群与场景
- 年龄≥18岁、因胸痛就诊于4个城市急诊且至少有1次肌钙蛋白检测结果的成人患者。
- 研究纳入实施前常规肌钙蛋白检测阶段(2021年6月1日至2022年3月31日)和实施后整合高敏肌钙蛋白路径阶段(2022年6月1日至2023年3月31日)的患者。
研究设计与关键结果
- 研究类型为回顾性质量改进研究,在单一医疗系统的4个城市急诊开展,共分析16094例患者就诊记录,其中女性9151例(56.9%),平均年龄49.5岁(SD 17.4)。
- 高敏肌钙蛋白队列8486例(52.7%),常规肌钙蛋白队列7608例(47.3%)。
- 主要终点:实施高敏肌钙蛋白路径与平均急诊停留时间从6.18小时(95%CI 6.10-6.26)降至5.64小时(95%CI 5.57-5.71)相关。
- 收住院患者平均急诊停留时间:常规肌钙蛋白10.50小时(95%CI 10.22-10.78) vs 高敏肌钙蛋白9.60小时(95%CI 9.35-9.87),P=0.003;离院患者:常规肌钙蛋白5.33小时(95%CI 5.26-5.40) vs 高敏肌钙蛋白5.02小时(95%CI 4.96-5.08),P=0.006。
- 接受2次及以上肌钙蛋白检测的患者评估至处置时间:常规肌钙蛋白6.68小时(95%CI 6.52-6.85) vs 高敏肌钙蛋白5.06小时(95%CI 4.97-5.15),P<0.001。
- 首次肌钙蛋白医嘱至第二次结果时间:收住院患者常规肌钙蛋白5.16小时(95%CI 5.01-5.31) vs 高敏肌钙蛋白3.18小时(95%CI 3.11-3.25),P<0.001;离院患者常规肌钙蛋白4.54小时(95%CI 4.46-4.62) vs 高敏肌钙蛋白2.78小时(95%CI 2.75-2.82),P<0.001。
证据类型、等级与局限
- 证据类型:回顾性质量改进研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在因胸痛就诊的成人急诊患者中,实施电子健康记录整合的高敏肌钙蛋白路径与急诊停留时间缩短相关,收住院和离院患者均如此。
- 在需要连续肌钙蛋白检测的患者中,该路径与评估至处置时间及首次肌钙蛋白医嘱至第二次结果时间缩短相关。
- 作者认为该结构化电子健康记录方法可能减轻高敏肌钙蛋白应用的运营挑战,并可作为改善胸痛患者急诊效率的可扩展模型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: High-sensitivity cardiac troponin (hs-cTn) assays are the diagnostic standard for acute coronary syndrome but present significant implementation and workflow complexity.
OBJECTIVE: To evaluate whether implementation of a structured, electronic health record (EHR)-integrated hs-cTn pathway was associated with changes in emergency department (ED) length of stay (LOS) and serial troponin testing times.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective quality improvement study compared preimplementation conventional cTn assay (June 1, 2021, to March 31, 2022) with a postimplementation integrated hs-cTn pathway (June 1, 2022, to March 31, 2023) in 4 urban EDs within a single health system. Participants were adults (aged ≥18 years) presenting with chest pain and at least 1 troponin assay result. Data analysis was performed from April to September 2024.
EXPOSURES: Implementation of an hs-cTn assay within an EHR-integrated clinical pathway.
MAIN OUTCOMES AND MEASURES: The primary outcome was ED LOS, defined as time from patient registration to ED departure. Secondary outcomes included time from first clinician evaluation to disposition (discharge or admission) and interval from the first troponin assay order to the second troponin assay result in patients with serial assays.
RESULTS: Of the 16 094 patient encounters analyzed (9151 [56.9%] female; mean [SD] age, 49.5 [17.4] years), 8486 (52.7%) were in the hs-cTn and 7608 (47.3%) were in the conventional cTn cohort. Overall, hs-cTn implementation with workflow integration was associated with decreased mean ED LOS, from 6.18 (95% CI, 6.10-6.26) hours to 5.64 (95% CI, 5.57-5.71) hours. Compared with conventional cTn, implementation of the hs-cTn pathway was associated with shorter mean ED LOS in admitted patients (9.60 [95% CI, 9.35-9.87] hours vs 10.50 [95% CI, 10.22-10.78] hours; P = .003) and discharged patients (5.02 [95% CI, 4.96-5.08] hours vs 5.33 [95% CI, 5.26-5.40] hours; P = .006). Pathway implementation was also associated with shorter time from evaluation to disposition in patients receiving 2 or more troponin measurements (5.06 [95% CI, 4.97-5.15] hours vs 6.68 [95% CI, 6.52-6.85] hours; P < .001) and time from first troponin order to second troponin result in both admitted patients (3.18 [95% CI, 3.11-3.25] hours vs 5.16 [95% CI, 5.01-5.31] hours; P < .001) and discharged patients (2.78 [95% CI, 2.75-2.82] hours vs 4.54 [95% CI, 4.46-4.62] hours; P < .001).
CONCLUSIONS AND RELEVANCE: In this quality improvement study, an EHR-integrated hs-cTn pathway was associated with significantly reduced ED LOS and, in patients with serial troponin measurements, reduced time from evaluation to disposition and reduced time to serial assay results. The findings suggest this structured EHR approach may mitigate operational challenges of hs-cTn adoption and could serve as a scalable model to improve ED efficiency for patients with chest pain.
参考来源
- Jia LZ, Israelyan N, Shofer FS, et al. High-Sensitivity Troponin Pathway and Emergency Department Length of Stay. JAMA Netw Open. 2026. PMID: 43007673. doi:10.1001/jamanetworkopen.2026.42980
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。